IRIS
RUSSO, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.794
EU - Europa 1.274
AS - Asia 296
SA - Sud America 46
OC - Oceania 32
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 26
Totale 5.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.561
IT - Italia 587
CA - Canada 228
SE - Svezia 224
GB - Regno Unito 206
IN - India 82
DE - Germania 61
CN - Cina 41
AU - Australia 31
RO - Romania 30
RU - Federazione Russa 29
TR - Turchia 23
EU - Europa 22
FR - Francia 21
FI - Finlandia 19
IL - Israele 17
BR - Brasile 16
CO - Colombia 16
ID - Indonesia 16
IR - Iran 16
PK - Pakistan 16
ES - Italia 13
JP - Giappone 13
UA - Ucraina 12
EG - Egitto 11
NL - Olanda 11
SG - Singapore 11
CL - Cile 10
GR - Grecia 10
PH - Filippine 10
ZA - Sudafrica 10
CH - Svizzera 9
TW - Taiwan 8
KR - Corea 7
MT - Malta 7
MY - Malesia 7
HK - Hong Kong 6
IE - Irlanda 5
PT - Portogallo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
MX - Messico 4
PL - Polonia 4
AF - Afghanistan, Repubblica islamica di 3
AR - Argentina 3
EE - Estonia 3
HR - Croazia 3
IQ - Iraq 3
MD - Moldavia 3
TH - Thailandia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
ET - Etiopia 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MN - Mongolia 2
OM - Oman 2
VN - Vietnam 2
BD - Bangladesh 1
BE - Belgio 1
CZ - Repubblica Ceca 1
GH - Ghana 1
GT - Guatemala 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
Totale 5.494
Salva come PNG Salva come JPEG
Città #
Chandler 994
Princeton 277
Lawrence 270
Ottawa 189
London 166
Wilmington 154
Catanzaro 152
Chicago 126
Des Moines 101
Ashburn 89
Redwood City 53
Milan 27
Norwalk 23
Redmond 21
Rome 21
Boardman 19
Helsinki 18
Pune 17
Melbourne 16
Padova 16
Timisoara 15
Falls Church 13
West Jordan 11
Bari 10
Bogotá 10
Florence 10
Los Angeles 10
Guangzhou 9
Hanover 9
Hyderabad 9
Latina 9
Messina 9
Nanjing 9
Philadelphia 9
Ann Arbor 8
Civitavecchia 8
Montreal 8
Naples 8
Toronto 8
Curinga 7
Horia 7
Santa Maria 7
Bengaluru 6
Fayetteville 6
Istanbul 6
Madrid 6
New York 6
Singapore 6
Augusta 5
Casalnuovo di Napoli 5
Clearwater 5
Collegeville 5
Esslingen am Neckar 5
Houston 5
Jakarta 5
Montague 5
Mountain View 5
Prato 5
Reading 5
Seattle 5
Seoul 5
Tel Aviv 5
Teresina 5
Torino 5
Zhengzhou 5
Beijing 4
Bollebygd 4
Bologna 4
Cagliari 4
Catania 4
Corigliano Calabro 4
Delhi 4
Durham 4
Eden Prairie 4
Giza 4
Kemerovo 4
Kochi 4
Ludhiana 4
Mumbai 4
Newark 4
Novokuznetsk 4
Nuremberg 4
Perth 4
Phoenix 4
Shanghai 4
Taipei 4
Tehran 4
Tokyo 4
Ahmedabad 3
Amsterdam 3
Ashdod 3
Aversa 3
Barcelona 3
Chisinau 3
Costabissara 3
Council Bluffs 3
Dallas 3
Dubai 3
Fergus 3
Fontebuona 3
Totale 3.201
Salva come PNG Salva come JPEG
Nome #
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 84
Role of anatomical variations in chronic non polipoid rhinosinusitis 84
Adherence to therapy and adverse drug reactions: is there a link? 80
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 61
Genetics of reflex seizures and epilepsies in humans and animals 58
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 56
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 54
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 47
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 44
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome 43
Efficacy and safety of bevacizumab in glioblastomas 41
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 41
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 40
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 40
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 40
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 40
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 39
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 39
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 38
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 37
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 37
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 36
Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy 36
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 34
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis An Observational Study 34
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 34
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 34
Pharmacokinetic considerations about antiseizure medications in the elderly 34
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 34
Management of status epilepticus in patients with liver or kidney disease: a narrative review 34
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 33
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 33
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 32
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 32
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 32
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 32
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 31
Melaena following use of the cholinesterase inhibitor rivastigmine 31
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 31
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 31
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 31
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. 30
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 30
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 30
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review 29
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 29
The potential role of cannabinoids in epilepsy treatment. 29
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 29
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 29
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 29
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 29
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 29
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 29
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 29
Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis 28
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 28
Microbiota-gut brain axis involvement in neuropsychiatric disorders 28
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 28
Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function 28
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System 28
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 28
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 27
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 27
Corticosteroid-related central nervous system side effects. 27
Renal denervation for resistant hypertension 27
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 27
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 27
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 27
Critical appraisal of cenobamate as adjunctive treatment of focal seizures in adults 27
Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. 26
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 26
Immediate and controlled-release pregabalin for the treatment of epilepsy 26
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 26
ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination 25
Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study. 25
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 25
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 25
Re: Nomenclature of drug-induced pityriasis rosea-like rashes 25
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 25
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 25
Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis 24
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 24
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 24
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs) 24
mTOR inhibition modulates epileptogenesis, seizures and depressive-like behavior in a genetic model of absence seizures and mild depression comorbidity: a role for inflammatory responses 24
Abatacept in psoriatic arthritis: Case report and short review. 24
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 24
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 24
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 24
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome 24
Status epilepticus in pregnancy: a literature review and a protocol proposal 23
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 23
Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports. 23
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 23
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 23
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 23
AMPA receptor antagonists as potential anticonvulsant drugs 23
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 23
Diagnostic Biomarkers of Epilepsy 23
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 23
Totale 3.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020380 0 0 0 15 32 22 17 20 24 23 86 141
2020/2021624 28 14 34 40 49 203 60 21 77 46 43 9
2021/2022947 19 14 20 229 39 32 30 180 113 91 149 31
2022/20232.619 585 215 90 236 245 231 18 186 405 167 179 62
2023/20241.238 205 176 139 109 103 260 82 53 24 79 8 0
Totale 5.808